Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.
2.

Genetic testing and risk assessment for spinal muscular atrophy (SMA).

Ogino S, Wilson RB.

Hum Genet. 2002 Dec;111(6):477-500. Epub 2002 Oct 3. Review.

PMID:
12436240
4.

Spinal muscular atrophy diagnostics.

Prior TW.

J Child Neurol. 2007 Aug;22(8):952-6. Review.

PMID:
17761649
5.

Spinal muscular atrophy: molecular genetics and diagnostics.

Ogino S, Wilson RB.

Expert Rev Mol Diagn. 2004 Jan;4(1):15-29. Review.

PMID:
14711346
6.

[Molecular basis of spinal muscular atrophy: th SMN gene].

Tizzano E, Baiget M.

Neurologia. 2000 Nov;15(9):393-400. Review. Spanish.

PMID:
11195146
7.

Best practice guidelines for molecular analysis in spinal muscular atrophy.

Scheffer H, Cobben JM, Matthijs G, Wirth B.

Eur J Hum Genet. 2001 Jul;9(7):484-91. Review.

8.

Spinal muscular atrophy: from gene to therapy.

Wirth B, Brichta L, Hahnen E.

Semin Pediatr Neurol. 2006 Jun;13(2):121-31. Review.

PMID:
17027862
9.

Molecular and cellular basis of spinal muscular atrophy.

Jablonka S, Sendtner M.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):144-9. Review.

PMID:
13129800
10.

Spinal muscular atrophy: state-of-the-art and therapeutic perspectives.

Wirth B.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2002 Jun;3(2):87-95. Review.

PMID:
12215230
11.

Spinal muscular atrophy: present state.

Schmalbruch H, Haase G.

Brain Pathol. 2001 Apr;11(2):231-47. Review.

PMID:
11303798
12.

Therapeutics development for spinal muscular atrophy.

Sumner CJ.

NeuroRx. 2006 Apr;3(2):235-45. Review.

13.

Is RNA manipulation a viable therapy for spinal muscular atrophy?

Horne C, Young PJ.

J Neurol Sci. 2009 Dec 15;287(1-2):27-31. doi: 10.1016/j.jns.2009.08.055. Epub 2009 Sep 15. Review.

PMID:
19758605
14.

Animal models of spinal muscular atrophy.

Monani UR, Coovert DD, Burghes AH.

Hum Mol Genet. 2000 Oct;9(16):2451-7. Review.

PMID:
11005801
15.

Perspectives and diagnostic considerations in spinal muscular atrophy.

Prior TW.

Genet Med. 2010 Mar;12(3):145-52. doi: 10.1097/GIM.0b013e3181c5e713. Review.

PMID:
20057317
16.

[Molecular genetic diagnosis and deletion analysis in Type I-III spinal muscular atrophy].

Spiegel R, Hagmann A, Boltshauser E, Moser H.

Schweiz Med Wochenschr. 1996 May 25;126(21):907-14. Review. German.

PMID:
8693311
17.

Therapeutics that directly increase SMN expression to treat spinal muscular atrophy.

Shababi M, Mattis VB, Lorson CL.

Drug News Perspect. 2010 Oct;23(8):475-82. doi: 10.1358/dnp.2010.23.8.1507295. Review.

PMID:
21031163
18.

Spinal muscular atrophy: from animal model to clinical trial.

Zanoteli E, Maximino JR, Conti Reed U, Chadi G.

Funct Neurol. 2010 Apr-Jun;25(2):73-9. Review.

PMID:
20923604
19.

Spinal muscular atrophy.

Talbot K, Davies KE.

Semin Neurol. 2001 Jun;21(2):189-97. Review.

PMID:
11442327
20.

Spinal muscular atrophy: from gene discovery to clinical trials.

Nurputra DK, Lai PS, Harahap NI, Morikawa S, Yamamoto T, Nishimura N, Kubo Y, Takeuchi A, Saito T, Takeshima Y, Tohyama Y, Tay SK, Low PS, Saito K, Nishio H.

Ann Hum Genet. 2013 Sep;77(5):435-63. doi: 10.1111/ahg.12031. Epub 2013 Jul 23. Review.

Supplemental Content

Support Center